These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2569679)

  • 21. Cerebral vasospasm and vasoconstriction caused by endothelin.
    Kobayashi H; Hayashi M; Kobayashi S; Kabuto M; Handa Y; Kawano H; Ide H
    Neurosurgery; 1991 May; 28(5):673-8; discussion 678-9. PubMed ID: 1876245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
    Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS
    J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin-1 of canine basilar artery in vasospasm.
    Yamaura I; Tani E; Maeda Y; Minami N; Shindo H
    J Neurosurg; 1992 Jan; 76(1):99-105. PubMed ID: 1727175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constrictor action of oxyhemoglobin in monkey and dog basilar arteries in vivo and in vitro.
    Toda N; Kawakami M; Yoshida K
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H420-5. PubMed ID: 1996685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs.
    Itoh S; Sasaki T; Ide K; Ishikawa K; Nishikibe M; Yano M
    Biochem Biophys Res Commun; 1993 Sep; 195(2):969-75. PubMed ID: 8373429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
    Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W
    Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of contractile responses to endothelin in human cerebral arteries: implications for cerebral vasospasm.
    Papadopoulos SM; Gilbert LL; Webb RC; D'Amato CJ
    Neurosurgery; 1990 May; 26(5):810-5. PubMed ID: 2191240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of cerebral vasodilation with endothelin-1.
    Kaito N; Onoue H; Abe T
    Peptides; 1995; 16(6):1127-32. PubMed ID: 8532597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathogenesis of cerebral vasospasm: with special references to the response of fresh human cerebral arteries to red blood cell hemolysate and the changes in the responses of cerebral arteries to vasoconstrictor substances after subarachnoid hemorrhage].
    Handa Y
    Nihon Geka Hokan; 1987 Mar; 56(2):124-37. PubMed ID: 3115214
    [No Abstract]   [Full Text] [Related]  

  • 30. Papaverine-sensitive vasospasm and arterial contractility and compliance after subarachnoid hemorrhage in dogs.
    Macdonald RL; Zhang J; Sima B; Johns L
    Neurosurgery; 1995 Nov; 37(5):962-7; discussion 967-8. PubMed ID: 8559346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of cerebral vasospasm by actinomycin D.
    Shigeno T; Mima T; Yanagisawa M; Saito A; Goto K; Yamashita K; Takenouchi T; Matsuura N; Yamasaki Y; Yamada K
    J Neurosurg; 1991 Jun; 74(6):940-3. PubMed ID: 2033454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional changes in cultured strips of canine cerebral arteries after prolonged exposure to oxyhemoglobin.
    Yoshimoto Y; Kim P; Sasaki T; Kirino T; Takakura K
    J Neurosurg; 1995 Nov; 83(5):867-74. PubMed ID: 7472556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model.
    Matsui T; Kaizu H; Itoh S; Asano T
    J Neurosurg; 1994 Feb; 80(2):276-82. PubMed ID: 8283267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of plasmin, thrombin, and antithrombin III as etiological factors in delayed cerebral vasospasm.
    White RP; Robertson JT
    Neurosurgery; 1985 Jan; 16(1):27-35. PubMed ID: 2579347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of vasoconstrictor actions of endothelin-1 in cerebral, coronary, and mesenteric arteries of the dog.
    Tanoi C; Suzuki Y; Shibuya M; Sugita K; Masuzawa-Ito K; Asano M
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):568-79. PubMed ID: 1380600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin-1 initiates the development of vasospasm after subarachnoid haemorrhage through protein kinase C activation, but does not contribute to prolonged vasospasm.
    Nishizawa S; Chen D; Yokoyama T; Yokota N; Otha S
    Acta Neurochir (Wien); 2000; 142(12):1409-15. PubMed ID: 11214636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid.
    Matsumura Y; Ikegawa R; Suzuki Y; Takaoka M; Uchida T; Kido H; Shinyama H; Hayashi K; Watanabe M; Morimoto S
    Life Sci; 1991; 49(11):841-8. PubMed ID: 1875792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin.
    Ito Y; Isotani E; Mizuno Y; Azuma H; Hirakawa K
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):45-50. PubMed ID: 10630732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.